SEARCH
🇬🇧
MEM
O
RY
.COM
4.37.48
Guest
Log In
Homepage
0
0
0
0
0
Create Course
Courses
Last Played
Dashboard
Notifications
Classrooms
Folders
Exams
Custom Exams
Help
Leaderboard
Shop
Awards
Forum
Friends
Subjects
Dark mode
User ID: 999999
Version: 4.37.48
www.memory.co.uk
You are in browse mode. You must login to use
MEM
O
RY
Log in to start
Index
»
PHARMACOLOGY 1
»
Drugs Neurodegenerative CHAPTER 8
»
Level 3
level: Level 3
Questions and Answers List
level questions: Level 3
Question
Answer
DOPAMINE RECEPTOR AGONISTS drugs LONGER duration of action than LEVODOPA LESS RISK of DYSKINESIA, MOTOR FLUCTUATIONS INEFFECTIVE for patients who have NOT responded to LEVODOPA
1 Bromocriptine 2 Ropinirole 3 Pramipexole 4 Rotigotine 5 Apomorphine
ERGOT DERIVATIVE. Similar action with LEVODOPA but hallucinations, confusion, delirium, nausea, and orthostatic hypotension are MORE COMMON DYSKINESIA is LESS PROMINENT May potentially cause PULMONARY & RETROPERITONEAL FIBROSIS May cause mental condition to WORSEN in Psychiatric Illness Used in CAUTION with MYOCARDIAL INFARCTION
Bromocriptine
for Parkinson's Disease 1 ORALLY ACTIVE AGENTS 2 INJECTABLE AND TRANSDERMAL
1 Pramipexole & Ropinirole 2 Apomorphine & Rotigotine
for Parkinson's Disease used for Acute Management of HYPOMOBILITY “off” phenomenon in ADVANCED Parkinson's disease
Apomorphine
administered as a ONCE DAILY transdermal patch that provides even drug levels over 24 hours
Rotigotine
INHIBITS the RENAL TUBULAR SECRETION of Organic Bases Significantly INCREASES the HALF LIFE of Pramipexole
Cimetidine
Used to treat INFLUENZA Has ANTIPARKINSONIAN ACTION LESS EFFICACIOUS than LEVODOPA High Doses: restlessness, agitation, confusion, hallucination May induce ACUTE TOXIC PSYCHOSIS
Amantadine